Related Experiment Video

Updated: Jun 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics

P D Williams1, J K Lee, D Theodorescu

  • 1Department of Public Health Sciences, Paul Mellon Urologic Cancer Institute, University of Virginia, Charlottesville, VA, U.S.A.

Current Oncology (Toronto, Ont.)
|February 21, 2009
PubMed

Insights

Cancer arises from complex cellular pathway dysregulation due to genetic mutations or epigenetic changes. Understanding tumor molecular characteristics is crucial for predicting disease progression and personalizing treatment response.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Cells possess intricate biological pathways regulated by diverse molecules.
  • Cancer develops when these cellular pathways deregulate due to genetic mutations or epigenetic alterations.
  • Pathway interconnectedness and multiple anticancer defenses contribute to cancer's heterogeneity.

Purpose of the Study:

  • To highlight the molecular basis of cancer heterogeneity.
  • To emphasize the need for individualized cancer treatment strategies.
  • To underscore the importance of molecular profiling for predicting tumor behavior and therapy response.

Main Methods:

  • Review of existing literature on cancer biology and molecular mechanisms.
  • Analysis of genetic and epigenetic factors contributing to tumorigenesis.
  • Correlation of molecular circuitry with tumor characteristics and treatment outcomes.

Main Results:

  • Diverse mutations and epigenetic changes can lead to deregulated cellular pathways and tumorigenesis.
  • Tumor heterogeneity arises from variations in molecular circuitry, impacting biological behavior.
  • Similar histology tumors can exhibit distinct molecular profiles, affecting clinical outcomes.

Conclusions:

  • Cancer is a family of related tumor subtypes, not a single disease.
  • Individualized prediction of disease progression and treatment response is essential.
  • Molecular characteristics of a tumor are key to personalized oncology.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...